The IL-22/IL-22R1 signaling axis has been commonly associated with the development and progression of numerous cancers, including gastrointestinal malignancies, by activating several signaling pathways, including the MAPK/ERK1/2 [86]. This evidence concerns the gene MAPK3 and cancer.